West Welcomes Robert McMahon as Incoming Chief Financial Officer
West Pharmaceutical Services (NYSE: WST) has appointed Robert McMahon as its new Chief Financial Officer, effective August 4, 2025. McMahon, who brings 34 years of healthcare industry experience, will succeed Bernard Birkett, who will transition to Senior Advisor to the CEO through year-end.
McMahon joins from Agilent Technologies, where he served as CFO since 2018, managing finance, audit, treasury, tax, investor relations, IT, and procurement. His previous roles include CFO at Hologic and various executive financial positions during a 20-year tenure at Johnson & Johnson. He currently serves as an Independent Director at OraSure Technologies since 2023.
West Pharmaceutical Services (NYSE: WST) ha nominato Robert McMahon come nuovo Chief Financial Officer, con decorrenza dal 4 agosto 2025. McMahon, che vanta 34 anni di esperienza nel settore sanitario, succederà a Bernard Birkett, che assumerà il ruolo di Senior Advisor del CEO fino alla fine dell'anno.
McMahon proviene da Agilent Technologies, dove ha ricoperto il ruolo di CFO dal 2018, gestendo finanza, audit, tesoreria, fiscalità, relazioni con gli investitori, IT e approvvigionamenti. In precedenza è stato CFO presso Hologic e ha ricoperto diverse posizioni finanziarie dirigenziali durante una carriera ventennale in Johnson & Johnson. Attualmente è Direttore Indipendente di OraSure Technologies dal 2023.
West Pharmaceutical Services (NYSE: WST) ha nombrado a Robert McMahon como su nuevo Director Financiero, con efecto a partir del 4 de agosto de 2025. McMahon, quien cuenta con 34 años de experiencia en la industria sanitaria, sucederá a Bernard Birkett, quien pasará a ser Asesor Senior del CEO hasta fin de año.
McMahon proviene de Agilent Technologies, donde se desempeñó como CFO desde 2018, gestionando finanzas, auditoría, tesorería, impuestos, relaciones con inversionistas, TI y adquisiciones. Anteriormente fue CFO en Hologic y ocupó varios cargos ejecutivos financieros durante una carrera de 20 años en Johnson & Johnson. Actualmente es Director Independiente en OraSure Technologies desde 2023.
West Pharmaceutical Services (NYSE: WST)는 Robert McMahon을 2025년 8월 4일부로 신임 최고재무책임자(CFO)로 임명했습니다. 의료 산업 분야에서 34년의 경력을 가진 McMahon은 Bernard Birkett의 뒤를 이어 CEO의 수석 고문으로 연말까지 활동할 예정입니다.
McMahon은 2018년부터 CFO로 재직하며 재무, 감사, 재무관리, 세무, 투자자 관계, IT, 조달을 담당했던 Agilent Technologies에서 합류했습니다. 이전에는 Hologic의 CFO와 Johnson & Johnson에서 20년간 다양한 재무 임원직을 역임했습니다. 현재는 2023년부터 OraSure Technologies의 독립 이사로 활동 중입니다.
West Pharmaceutical Services (NYSE : WST) a nommé Robert McMahon en tant que nouveau Directeur Financier, à compter du 4 août 2025. Fort de 34 années d'expérience dans le secteur de la santé, McMahon succédera à Bernard Birkett, qui deviendra Conseiller Principal du PDG jusqu'à la fin de l'année.
McMahon rejoint la société en provenance de Agilent Technologies, où il occupait le poste de CFO depuis 2018, supervisant les finances, l'audit, la trésorerie, la fiscalité, les relations investisseurs, l'informatique et les achats. Il a auparavant été CFO chez Hologic et a occupé divers postes financiers de direction durant une carrière de 20 ans chez Johnson & Johnson. Il est actuellement administrateur indépendant chez OraSure Technologies depuis 2023.
West Pharmaceutical Services (NYSE: WST) hat Robert McMahon mit Wirkung zum 4. August 2025 zum neuen Chief Financial Officer ernannt. McMahon, der über 34 Jahre Erfahrung in der Gesundheitsbranche verfügt, wird Bernard Birkett nachfolgen, der bis Jahresende als Senior Advisor des CEO tätig sein wird.
McMahon kommt von Agilent Technologies, wo er seit 2018 als CFO tätig war und Finanzen, Prüfung, Treasury, Steuern, Investor Relations, IT und Beschaffung leitete. Zuvor war er CFO bei Hologic und bekleidete verschiedene leitende Finanzpositionen während seiner 20-jährigen Tätigkeit bei Johnson & Johnson. Seit 2023 ist er zudem unabhängiges Mitglied im Vorstand von OraSure Technologies.
- Appointment of experienced CFO with 34 years of healthcare industry expertise
- Strong leadership background from major companies including Agilent, Hologic, and Johnson & Johnson
- Planned transition period with current CFO ensuring operational continuity
- Loss of institutional knowledge with departure of current CFO Bernard Birkett
"Bob is an accomplished CFO and business executive within the healthcare industry who has guided several companies through dynamic environments and meaningful financial transformation during his impressive 34-year career. He brings a proven track record of delivering strong financial results, implementing effective financial and operational strategies, and demonstrating inspirational leadership," said Eric M. Green, President, Chief Executive Officer and Chair of the Board. "I'm pleased to welcome Bob to the West team and am confident that his expertise will be instrumental in helping steer our company forward and generating long-term shareholder value."
Mr. McMahon has been Chief Financial Officer of Agilent Technologies Inc. since 2018. In this role, he is responsible for finance, audit, treasury, tax, investor relations, IT and procurement. Prior to Agilent, Mr. McMahon was the CFO at Hologic, Inc. and spent 20 years with Johnson & Johnson, in executive financial roles of increasing responsibility. He has also served as an Independent Director at OraSure Technologies, Inc. since 2023.
"I'm excited by the opportunity to join such a well-positioned company with a talented team dedicated to improving patient health," said Mr. McMahon. "With a history of innovation spanning more than a century, I look forward to working alongside Eric and the leadership team to play a meaningful role in charting the next chapter of West's growth story for all stakeholders."
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-welcomes-robert-mcmahon-as-incoming-chief-financial-officer-302508951.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
Who is the new CFO of West Pharmaceutical Services (NYSE: WST)?
What is Robert McMahon's experience before joining West Pharmaceutical Services?
When will Robert McMahon start as WST's CFO?
Who is Robert McMahon replacing at West Pharmaceutical Services?
What are Robert McMahon's responsibilities at West Pharmaceutical Services?
